Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pTVG-HP DNA vaccine in non-metastatic prostate cancer
NCT01341652Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2011
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
A Phase 2 trial of pTVG-HP plasmid DNA vaccine in prostate cancer (PCa), sponsored by University of Wisconsin–Madison. Started May 2011; status: completed.
02
Drugs
pTVG-HP plasmid DNA vaccine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01341652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341652.